Biomarker-driven Prioritization

Biomarker-Driven Prioritization is a therapeutic area prioritization method that uses biomarker data to identify and rank disease targets based on their molecular characteristics, distinguishing it from other prioritization approaches by its reliance on quantifiable biological indicators to guide decision-making.

5

Publications

110

Citations

177

Authors

19

Institutions

Publications per year

2017–2026

5

Authors

177

  1. DH
    Dena Hernandez

    National Institute on Aging, United States

    1 publications · 50 citations

    1

    h-index

  2. MM
    Manuel Mayhaus

    University College London, United Kingdom

    1 publications · 50 citations

    1

    h-index

  3. LB
    Lauren Bartley

    Neuroscience Research Australia, Australia

    1 publications · 50 citations

    1

    h-index

  4. HR
    Huw R. Morris

    University College London, United Kingdom

    1 publications · 50 citations

    1

    h-index

  5. CF
    Chiara Fenoglio

    University of Milan, Italy

    1 publications · 50 citations

    1

    h-index

1–5 of 177

Venues

  1. Bioengineering

    1 publications · 19 citations

    1

    h-index

  2. Journal of Applied Biomedicine

    1 publications · 13 citations

    1

    h-index

  3. Biological Psychiatry

    1 publications · 50 citations

    1

    h-index

  4. Expert Systems with Applications

    1 publications · 18 citations

    1

    h-index

  5. BMC Medical Informatics and Decision Making

    1 publications · 10 citations

1–5